Savara Inc

NASDAQ:SVRA

3.28

+0.01 (+0.31%)

4:26:11 PM EDT: $3.33 +0.05 (+1.52%)

Savara Inc Stock, NASDAQ:SVRA

One Summit Square, 1717 Langhorne Newtown Road, Langhorne, Pennsylvania 19047

United States of America

Phone: +1.512.614.1848

Number of Employees: 37

http://www.savarapharma.com

Description

Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in December 1995 and is headquartered in Langhorne, PA.